Liver cirrhosis is most commonly divided into four clinical stages, though the answer depends on which staging system your doctor is using. Some systems focus on how much scarring exists in the liver tissue, while others focus on how well your liver is still functioning. Understanding where you fall on these scales tells you a lot about what to expect going forward.
The Four Clinical Stages
The most intuitive way to understand cirrhosis progression is a four-stage system based on whether complications have appeared. Stages 1 and 2 are considered “compensated,” meaning your liver is damaged but still managing to do its job. Stages 3 and 4 are “decompensated,” meaning the liver can no longer keep up.
- Stage 1: No varices (swollen veins in the esophagus or stomach) and no fluid buildup in the abdomen. You likely have no symptoms at all.
- Stage 2: Varices have developed, but there’s still no fluid buildup or bleeding. You may still feel relatively normal.
- Stage 3: Fluid is accumulating in the abdomen (called ascites), with or without variceal bleeding. This marks the shift into decompensated cirrhosis.
- Stage 4: Bleeding from varices has occurred, often alongside other serious complications like confusion caused by toxin buildup in the brain.
The transition from compensated to decompensated cirrhosis happens at a rate of roughly 5 to 7% per year. That shift is the single most important turning point in the disease, because survival rates drop significantly once complications appear.
The Fibrosis Scale: F0 Through F4
Before cirrhosis is even diagnosed, doctors often track liver scarring using the METAVIR scoring system, which has five stages ranging from F0 to F4. This scale covers the entire spectrum of liver fibrosis, not just cirrhosis itself:
- F0: No fibrosis. Your liver tissue is healthy.
- F1: Mild fibrosis. Minor scarring has started.
- F2: Significant fibrosis. Scarring is now considered clinically meaningful.
- F3: Advanced fibrosis, sometimes called “bridging fibrosis” because scar tissue is connecting different areas of the liver.
- F4: Cirrhosis. Scarring is extensive and has reshaped the liver’s internal structure.
The term “cirrhosis” is reserved specifically for F4. So when someone says they have cirrhosis, they’re already at the final stage of the fibrosis scale. Everything that happens after that point, the progression from compensated to decompensated disease, is tracked using other tools.
How Liver Function Is Scored
Once cirrhosis is confirmed, the Child-Pugh score is the most widely used tool for grading its severity. It evaluates five things: how well your blood clots, the level of a protein called albumin in your blood, the level of bilirubin (a waste product that causes yellowing), whether fluid has built up in your abdomen, and whether liver disease is affecting your brain function. Each factor gets 1 to 3 points, and the total places you into one of three classes.
Class A (5 to 6 points) means your liver is still functioning reasonably well. One-year survival for Class A is close to 100%, and two-year survival is around 85%. Class B (7 to 9 points) indicates moderate damage, with one-year survival dropping to about 80% and two-year survival to 60%. Class C (10 to 15 points) reflects severe damage. One-year survival falls to roughly 45%, and two-year survival to about 35%.
These numbers make it clear why staging matters. The gap between Class A and Class C is enormous in practical terms, and knowing your class helps guide decisions about treatment intensity and whether a liver transplant should be considered.
How Cirrhosis Is Measured Without a Biopsy
A liver biopsy used to be the standard way to determine your fibrosis stage, but many doctors now use a FibroScan instead. This painless ultrasound-based test measures liver stiffness in kilopascals (kPa). Stiffer tissue means more scarring.
General ranges look like this: below 6 kPa is considered normal (F0), 6 to 7 kPa suggests mild fibrosis (F1), 7 to 9 kPa indicates significant fibrosis (F2), 9.1 to 10.3 kPa points to advanced fibrosis (F3), and anything at or above 10.4 kPa is in the cirrhosis range (F4). These cutoffs can vary slightly depending on the underlying liver condition, so your doctor may interpret your results in context.
What Decompensated Cirrhosis Looks Like
The complications that define decompensated cirrhosis are driven largely by portal hypertension, a condition where scarring forces blood pressure to rise in the vein that feeds the liver. That increased pressure pushes blood into smaller veins that weren’t designed to handle it, particularly in the esophagus and stomach. These swollen veins (varices) can rupture and cause life-threatening bleeding.
Fluid buildup in the abdomen is another hallmark. It can cause visible swelling, discomfort, and difficulty breathing. Meanwhile, when the damaged liver can no longer filter toxins effectively, those toxins accumulate in the brain. This leads to hepatic encephalopathy, which starts with difficulty concentrating and mental fogginess and can progress to confusion, personality changes, or even coma in advanced cases. Yellowing of the skin and eyes (jaundice) also becomes more likely as the liver loses its ability to process bilirubin.
Can Early Cirrhosis Be Reversed?
In its advanced stages, cirrhosis is generally considered irreversible, and a liver transplant may be the only option. But in earlier stages, particularly compensated cirrhosis, treating the underlying cause can sometimes improve or even reverse the damage. For example, eliminating hepatitis C with antiviral therapy, stopping alcohol use, or managing autoimmune liver disease can all allow the liver to heal to some degree.
This is one of the strongest arguments for catching cirrhosis early. If you’re at F4 on a fibrosis scale but still in the compensated phase with a Child-Pugh Class A score, aggressive treatment of the root cause gives your liver its best chance at recovery. Once decompensation sets in, the focus shifts from reversal to managing complications and evaluating transplant eligibility. The MELD score, which factors in kidney function, blood clotting, bilirubin, sodium levels, and sex, is the primary tool used to prioritize patients on transplant waiting lists.